SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

NEXT STORY
Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results
PREV STORY
Calithera Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

US Patent Office issues Notice of Allowance status for NRGBiotic™ for treating, preventing, or Ameliorating depression or a Depressive disorder.

author_avatar
NASDAQ Market News

Menē Inc. Reports Financial Results for the Fourth Quarter and Fiscal Year 2020

author_avatar
NASDAQ Market News

Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02

author_avatar
NASDAQ Market News